U.S. invests $170 million in late-stage Ebola vaccines, drugs

CHICAGO (Reuters) - The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Administration.

Medicare patients face high costs for newer injected cholesterol drugs

(Reuters Health) - Newer injected cholesterol medicines known as PCSK9 inhibitors can cost Medicare patients more than $300 a month, compared with only about $4 for older statin pills to lower cholesterol, a U.S. study suggests.

U.S. judge clears way for Maryland drug price-gouging law

(Reuters) - A U.S. District Court judge on Friday cleared the way for Maryland to implement the nation's first law designed to penalize drugmakers for price gouging by denying the generic drug industry trade group's request for an injunction.